Core Laboratories: A Speculative Buy At Present Levels (NYSE:CLB)
Core Laboratories has just come through an awful quarter and its shares are reflective of that. See why I rate CLB stock a speculative Buy.
Stay updated with breaking news from Evaluation Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Core Laboratories has just come through an awful quarter and its shares are reflective of that. See why I rate CLB stock a speculative Buy.
/PRNewswire/ -- Anchin, a premiere New-York based full-service accounting and advisory firm, is pleased to announce that four experienced professionals have...
Dr. Shalon’s Maternal Action Project (DSMAP), a national leader in maternal health, is pleased to announce the appointment of Ndidiamaka...
FON announced today that Michael Twyman has joined the FON organization as its Entrepreneur-in-Residence. Mr. Twyman is responsible for defining and executing
Press release content from Accesswire. The AP news staff was not involved in its creation.